APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Taurine and Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Taurine and Derivatives Market Outlook and Growth Opportunities 2026

Report ID 173365360430 December 2025192 pages

Choose your research edition.

Industry ResearchTaurine and Derivatives Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Taurine and Derivatives Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Taurine and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Taurine and Derivatives Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Taurine and Derivatives Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Taurine and Derivatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Taurine and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Taurine and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Taurine and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Taurine and Derivatives market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Taurine and Derivatives market include Taisho Pharmaceutical, Yuanyang Pharmaceutical, Jiangyin Huachang, Yongan Pharmaceutical, Zhejiang NHU Co., Ltd and Grand Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Taurine and Derivatives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Taurine and Derivatives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Taurine and Derivatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Taurine and Derivatives market size, projected growth trends, production technologies, key applications, and end-use industries.

Taurine and Derivatives Segment by Company

Taisho Pharmaceutical

Yuanyang Pharmaceutical

Jiangyin Huachang

Yongan Pharmaceutical

Zhejiang NHU Co., Ltd

Grand Pharma

Taurine and Derivatives Segment by Type

Taurine

Taurine Derivatives

Taurine and Derivatives Segment by Application

Beverages

Pet Food

Health Products

Others

Taurine and Derivatives Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Taurine and Derivatives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Taurine and Derivatives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Taurine and Derivatives significant trends, drivers, influence factors in global and regions.

6. To analyze Taurine and Derivatives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taurine and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Taurine and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taurine and Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Taurine and Derivatives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Taurine and Derivatives industry.

Chapter 3: Detailed analysis of Taurine and Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Taurine and Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Taurine and Derivatives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Taurine and Derivatives Industry Trends Table 2. Taurine and Derivatives Industry Drivers Table 3. Taurine and Derivatives Industry Opportunities and Challenges Table 4. Taurine and Derivatives Industry Restraints Table 5. Global Taurine and Derivatives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Taurine and Derivatives Revenue Share by Company (2021-2026) Table 7. Global Taurine and Derivatives Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Taurine and Derivatives Sales Volume Share by Company (2021-2026) Table 9. Global Taurine and Derivatives Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Taurine and Derivatives Company Ranking, (2024-2026) & (USD Million) Table 11. Global Taurine and Derivatives Key Company Manufacturing Base & Headquarters Table 12. Global Taurine and Derivatives Company, Product Type & Application Table 13. Global Taurine and Derivatives Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Taurine and Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Taurine Table 18. Significant Companies of Taurine Derivatives Table 19. Global Taurine and Derivatives Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Taurine and Derivatives Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Taurine and Derivatives Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Taurine and Derivatives Sales Volume Share by Type (2021-2026) Table 23. Global Taurine and Derivatives Sales Volume Share by Type (2027-2032) Table 24. Global Taurine and Derivatives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Taurine and Derivatives Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Taurine and Derivatives Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Taurine and Derivatives Sales Value Share by Type (2021-2026) Table 28. Global Taurine and Derivatives Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Beverages Table 30. Significant Companies of Pet Food Table 31. Significant Companies of Health Products Table 32. Significant Companies of Others Table 33. Global Taurine and Derivatives Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Taurine and Derivatives Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Taurine and Derivatives Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Taurine and Derivatives Sales Volume Share by Application (2021-2026) Table 37. Global Taurine and Derivatives Sales Volume Share by Application (2027-2032) Table 38. Global Taurine and Derivatives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Taurine and Derivatives Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Taurine and Derivatives Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Taurine and Derivatives Sales Value Share by Application (2021-2026) Table 42. Global Taurine and Derivatives Sales Value Share by Application (2027-2032) Table 43. Global Taurine and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Taurine and Derivatives Sales by Region (2021-2026) & (Tons) Table 45. Global Taurine and Derivatives Sales Market Share by Region (2021-2026) Table 46. Global Taurine and Derivatives Sales by Region (2027-2032) & (Tons) Table 47. Global Taurine and Derivatives Sales Market Share by Region (2027-2032) Table 48. Global Taurine and Derivatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Taurine and Derivatives Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Taurine and Derivatives Sales Value Share by Region (2021-2026) Table 51. Global Taurine and Derivatives Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Taurine and Derivatives Sales Value Share by Region (2027-2032) Table 53. Global Taurine and Derivatives Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Taurine and Derivatives Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Taurine and Derivatives Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Taurine and Derivatives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Taurine and Derivatives Sales by Country (2021-2026) & (Tons) Table 58. Global Taurine and Derivatives Sales Market Share by Country (2021-2026) Table 59. Global Taurine and Derivatives Sales by Country (2027-2032) & (Tons) Table 60. Global Taurine and Derivatives Sales Market Share by Country (2027-2032) Table 61. Global Taurine and Derivatives Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Taurine and Derivatives Sales Value Market Share by Country (2021-2026) Table 63. Global Taurine and Derivatives Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Taurine and Derivatives Sales Value Market Share by Country (2027-2032) Table 65. Taisho Pharmaceutical Company Information Table 66. Taisho Pharmaceutical Business Overview Table 67. Taisho Pharmaceutical Taurine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Taisho Pharmaceutical Taurine and Derivatives Product Portfolio Table 69. Taisho Pharmaceutical Recent Development Table 70. Yuanyang Pharmaceutical Company Information Table 71. Yuanyang Pharmaceutical Business Overview Table 72. Yuanyang Pharmaceutical Taurine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Yuanyang Pharmaceutical Taurine and Derivatives Product Portfolio Table 74. Yuanyang Pharmaceutical Recent Development Table 75. Jiangyin Huachang Company Information Table 76. Jiangyin Huachang Business Overview Table 77. Jiangyin Huachang Taurine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Jiangyin Huachang Taurine and Derivatives Product Portfolio Table 79. Jiangyin Huachang Recent Development Table 80. Yongan Pharmaceutical Company Information Table 81. Yongan Pharmaceutical Business Overview Table 82. Yongan Pharmaceutical Taurine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Yongan Pharmaceutical Taurine and Derivatives Product Portfolio Table 84. Yongan Pharmaceutical Recent Development Table 85. Zhejiang NHU Co., Ltd Company Information Table 86. Zhejiang NHU Co., Ltd Business Overview Table 87. Zhejiang NHU Co., Ltd Taurine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Zhejiang NHU Co., Ltd Taurine and Derivatives Product Portfolio Table 89. Zhejiang NHU Co., Ltd Recent Development Table 90. Grand Pharma Company Information Table 91. Grand Pharma Business Overview Table 92. Grand Pharma Taurine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Grand Pharma Taurine and Derivatives Product Portfolio Table 94. Grand Pharma Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Taurine and Derivatives Distributors List Table 98. Taurine and Derivatives Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Taurine and Derivatives Product Image Figure 2. Global Taurine and Derivatives Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Taurine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 4. Global Taurine and Derivatives Sales (2021-2032) & (Tons) Figure 5. Global Taurine and Derivatives Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Taurine and Derivatives Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Taurine Image Figure 10. Taurine Derivatives Image Figure 11. Global Taurine and Derivatives Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Taurine and Derivatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Taurine and Derivatives Sales Volume Share by Type (2021-2032) Figure 14. Global Taurine and Derivatives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Taurine and Derivatives Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Taurine and Derivatives Sales Value Share by Type (2021-2032) Figure 17. Beverages Image Figure 18. Pet Food Image Figure 19. Health Products Image Figure 20. Others Image Figure 21. Global Taurine and Derivatives Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Taurine and Derivatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Taurine and Derivatives Sales Volume Share by Application (2021-2032) Figure 24. Global Taurine and Derivatives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Taurine and Derivatives Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Taurine and Derivatives Sales Value Share by Application (2021-2032) Figure 27. Global Taurine and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Taurine and Derivatives Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Taurine and Derivatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Taurine and Derivatives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Taurine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 32. North America Taurine and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Taurine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Taurine and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Taurine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Taurine and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Taurine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 38. South America Taurine and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Taurine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Taurine and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Taurine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Taurine and Derivatives Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Taurine and Derivatives Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Taurine
  • Taurine Derivatives
Applications
  • Beverages
  • Pet Food
  • Health Products
  • Others
Companies covered
  • Taisho Pharmaceutical
  • Yuanyang Pharmaceutical
  • Jiangyin Huachang
  • Yongan Pharmaceutical
  • Zhejiang NHU Co., Ltd
  • Grand Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Taurine and Derivatives Sales Value (2021-2032)
  4. 1.2.2 Global Taurine and Derivatives Sales Volume (2021-2032)
  5. 1.2.3 Global Taurine and Derivatives Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Taurine and Derivatives Market Dynamics
  1. 2.1 Taurine and Derivatives Industry Trends
  2. 2.2 Taurine and Derivatives Industry Drivers
  3. 2.3 Taurine and Derivatives Industry Opportunities and Challenges
  4. 2.4 Taurine and Derivatives Industry Restraints
3 Taurine and Derivatives Market by Company
  1. 3.1 Global Taurine and Derivatives Company Revenue Ranking in 2025
  2. 3.2 Global Taurine and Derivatives Revenue by Company (2021-2026)
  3. 3.3 Global Taurine and Derivatives Sales Volume by Company (2021-2026)
  4. 3.4 Global Taurine and Derivatives Average Price by Company (2021-2026)
  5. 3.5 Global Taurine and Derivatives Company Ranking (2024-2026)
  6. 3.6 Global Taurine and Derivatives Company Manufacturing Base and Headquarters
  7. 3.7 Global Taurine and Derivatives Company Product Type and Application
  8. 3.8 Global Taurine and Derivatives Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Taurine and Derivatives Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Taurine and Derivatives Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Taurine and Derivatives Market by Type
  1. 4.1 Taurine and Derivatives Type Introduction
  2. 4.1.1 Taurine
  3. 4.1.2 Taurine Derivatives
  4. 4.2 Global Taurine and Derivatives Sales Volume by Type
  5. 4.2.1 Global Taurine and Derivatives Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Taurine and Derivatives Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Taurine and Derivatives Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Taurine and Derivatives Sales Value by Type
  9. 4.3.1 Global Taurine and Derivatives Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Taurine and Derivatives Sales Value by Type (2021-2032)
  11. 4.3.3 Global Taurine and Derivatives Sales Value Share by Type (2021-2032)
5 Taurine and Derivatives Market by Application
  1. 5.1 Taurine and Derivatives Application Introduction
  2. 5.1.1 Beverages
  3. 5.1.2 Pet Food
  4. 5.1.3 Health Products
  5. 5.1.4 Others
  6. 5.2 Global Taurine and Derivatives Sales Volume by Application
  7. 5.2.1 Global Taurine and Derivatives Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Taurine and Derivatives Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Taurine and Derivatives Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Taurine and Derivatives Sales Value by Application
  11. 5.3.1 Global Taurine and Derivatives Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Taurine and Derivatives Sales Value by Application (2021-2032)
  13. 5.3.3 Global Taurine and Derivatives Sales Value Share by Application (2021-2032)
6 Taurine and Derivatives Regional Sales and Value Analysis
  1. 6.1 Global Taurine and Derivatives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Taurine and Derivatives Sales by Region (2021-2032)
  3. 6.2.1 Global Taurine and Derivatives Sales by Region: 2021-2026
  4. 6.2.2 Global Taurine and Derivatives Sales by Region (2027-2032)
  5. 6.3 Global Taurine and Derivatives Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Taurine and Derivatives Sales Value by Region (2021-2032)
  7. 6.4.1 Global Taurine and Derivatives Sales Value by Region: 2021-2026
  8. 6.4.2 Global Taurine and Derivatives Sales Value by Region (2027-2032)
  9. 6.5 Global Taurine and Derivatives Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Taurine and Derivatives Sales Value (2021-2032)
  12. 6.6.2 North America Taurine and Derivatives Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Taurine and Derivatives Sales Value (2021-2032)
  15. 6.7.2 Europe Taurine and Derivatives Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Taurine and Derivatives Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Taurine and Derivatives Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Taurine and Derivatives Sales Value (2021-2032)
  21. 6.9.2 South America Taurine and Derivatives Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Taurine and Derivatives Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Taurine and Derivatives Sales Value Share by Country, 2025 VS 2032
7 Taurine and Derivatives Country-level Sales and Value Analysis
  1. 7.1 Global Taurine and Derivatives Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Taurine and Derivatives Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Taurine and Derivatives Sales by Country (2021-2032)
  4. 7.3.1 Global Taurine and Derivatives Sales by Country (2021-2026)
  5. 7.3.2 Global Taurine and Derivatives Sales by Country (2027-2032)
  6. 7.4 Global Taurine and Derivatives Sales Value by Country (2021-2032)
  7. 7.4.1 Global Taurine and Derivatives Sales Value by Country (2021-2026)
  8. 7.4.2 Global Taurine and Derivatives Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Taurine and Derivatives Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Taurine and Derivatives Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Taurine and Derivatives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Taisho Pharmaceutical
  2. 8.1.1 Taisho Pharmaceutical Company Information
  3. 8.1.2 Taisho Pharmaceutical Business Overview
  4. 8.1.3 Taisho Pharmaceutical Taurine and Derivatives Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Taisho Pharmaceutical Taurine and Derivatives Product Portfolio
  6. 8.1.5 Taisho Pharmaceutical Recent Developments
  7. 8.2 Yuanyang Pharmaceutical
  8. 8.2.1 Yuanyang Pharmaceutical Company Information
  9. 8.2.2 Yuanyang Pharmaceutical Business Overview
  10. 8.2.3 Yuanyang Pharmaceutical Taurine and Derivatives Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yuanyang Pharmaceutical Taurine and Derivatives Product Portfolio
  12. 8.2.5 Yuanyang Pharmaceutical Recent Developments
  13. 8.3 Jiangyin Huachang
  14. 8.3.1 Jiangyin Huachang Company Information
  15. 8.3.2 Jiangyin Huachang Business Overview
  16. 8.3.3 Jiangyin Huachang Taurine and Derivatives Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jiangyin Huachang Taurine and Derivatives Product Portfolio
  18. 8.3.5 Jiangyin Huachang Recent Developments
  19. 8.4 Yongan Pharmaceutical
  20. 8.4.1 Yongan Pharmaceutical Company Information
  21. 8.4.2 Yongan Pharmaceutical Business Overview
  22. 8.4.3 Yongan Pharmaceutical Taurine and Derivatives Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Yongan Pharmaceutical Taurine and Derivatives Product Portfolio
  24. 8.4.5 Yongan Pharmaceutical Recent Developments
  25. 8.5 Zhejiang NHU Co., Ltd
  26. 8.5.1 Zhejiang NHU Co., Ltd Company Information
  27. 8.5.2 Zhejiang NHU Co., Ltd Business Overview
  28. 8.5.3 Zhejiang NHU Co., Ltd Taurine and Derivatives Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang NHU Co., Ltd Taurine and Derivatives Product Portfolio
  30. 8.5.5 Zhejiang NHU Co., Ltd Recent Developments
  31. 8.6 Grand Pharma
  32. 8.6.1 Grand Pharma Company Information
  33. 8.6.2 Grand Pharma Business Overview
  34. 8.6.3 Grand Pharma Taurine and Derivatives Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Grand Pharma Taurine and Derivatives Product Portfolio
  36. 8.6.5 Grand Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Taurine and Derivatives Value Chain Analysis
  2. 9.1.1 Taurine and Derivatives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Taurine and Derivatives Sales Mode & Process
  6. 9.2 Taurine and Derivatives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Taurine and Derivatives Distributors
  9. 9.2.3 Taurine and Derivatives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst